Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Nurx Introduces Convenient & Stigma-Free Treatment for Herpes
  • USA - English

In addition to offering online consultations and home delivery of medication, the health tech company accepts health insurance and offers transparent pricing


News provided by

Nurx

Jan 14, 2020, 18:00 ET

Share this article

Share toX

Share this article

Share toX

Nurx now offers its patients the ability to manage outbreaks on their own time with online consultations and home delivery of medication.
Nurx now offers its patients the ability to manage outbreaks on their own time with online consultations and home delivery of medication.

SAN FRANCISCO, Jan. 14, 2020 /PRNewswire-PRWeb/ -- Nurx, the health tech company providing convenient and affordable care for sensitive health needs, today introduced treatment for people living with oral and genital herpes through its telemedicine platform. Nurx now offers its patients the ability to manage outbreaks on their own time with online consultations and home delivery of medication, eliminating the need to make an appointment, travel to a clinic, or wait in line at the pharmacy.

Herpes is incredibly common - an estimated 1 in 2 people have oral herpes and 1 in 6 people have genital herpes1 - and outbreaks are easily manageable with prescription-strength medication. This new health service is another example of how Nurx is committed to addressing highly-stigmatized health conditions, leveraging telemedicine to connect patients with compassionate medical providers that will help them take charge of their sensitive healthcare decisions on their own time. As with all of its healthcare services, the company is committed to providing its patients with transparent and affordable pricing by accepting most health insurance and offering cost-effective options for those who are uninsured.

"In addition to making it as convenient as possible for our patients to manage their outbreaks, our clinical team is committed to providing our patients with compassionate care while making it clear that herpes does not need to get in the way of having a normal sex life," said Nurx CEO Varsha Rao.

Post this

Nurx is also uniquely positioned to provide women with treatment, considering more than 200,000 women choose Nurx for their health needs and 1 in 5 women are living with genital herpes.2 The company will also provide genital herpes treatment to pregnant women. Neonatal herpes is a serious and often fatal condition, and if a pregnant woman has an outbreak at the time of delivery, there is a very high risk of spreading herpes to her infant. While the company will advocate for pregnant women to receive prenatal care from their local provider, the company recognizes there is a significant access gap for prenatal health services and is compelled to offer medication that is safe for pregnant women and potentially life-saving for their future child.

"The experience of seeking treatment for herpes can often be confusing, uncomfortable, isolating, and nerve-wracking," said Nurx CEO Varsha Rao. "We can't prevent the spread of herpes without addressing the stigma often associated with herpes. In addition to making it as convenient as possible for our patients to manage their outbreaks, our clinical team is committed to providing our patients with compassionate care while making it clear that herpes does not need to get in the way of having a normal sex life."

According to a recent national survey conducted by the company, there is a clear knowledge gap when it comes to herpes, with only 5 percent of respondents correctly answering how many people are living with oral herpes, and 75 percent of respondents underestimating how many people are living with genital herpes. As part of its mission to empower people to make informed decisions about their health, Nurx is committed to addressing the overblown fear and stigma associated with herpes. Nurx's "Knowledge Center", which provides over 500 expert answers on a wide variety of sensitive health topics, will address common misperceptions about herpes, as well as guidance on how to manage outbreaks and live with herpes.

With over 200,000 current patients across the country, providing treatment for herpes is yet another example of how the company is addressing rising rates of sexually transmitted infections. In addition to PrEP for HIV prevention and HPV home testing for cervical cancer screening, the company most recently introduced STI home test kits and treatment and has already provided thousands of its patients with information about their STI status. Nurx is also the leading online provider for contraception, offering comprehensive options for birth control and emergency contraception.

After a patient shares their health history through the Nurx app, their Nurx medical provider will consult with the patient regarding their request within 1-2 days while the Nurx platform checks their insurance. If approved by their Nurx provider, medication arrives in discreet packaging at the patient's home within 3-5 days. After their initial consultation or exam, Nurx patients also have unlimited access to their provider, allowing them to ask as many questions about this health condition as they'd like.

Nurx eliminates the average wait time of 24 days to find an available doctor's appointment3, as well as the average two hours Americans spend driving to a doctor's office, sitting in the waiting room, and filling out forms for a limited amount of face-to-face time with the doctor.4

Nurx is offering the most effective medication to manage outbreaks, and this treatment will be available to patients in 27 states and the District of Columbia, encompassing 85 percent of the U.S. population. Patients can learn more at nurx.com/genital-herpes-treatment

About Nurx
Nurx is a health tech company providing convenient, affordable, and personalized care for sensitive health needs. By reimagining the healthcare experience, Nurx offers patients transparent pricing and judgment-free care whenever and wherever works best for them. We believe everyone should have the freedom to live well and be in charge of their healthcare decisions, regardless of their circumstances. From diagnosis to delivery, we make every part of getting healthy and staying healthy, better.

1Centers for Disease Control
2Centers for Disease Control
3Merritt Hawkins
4American Journal of Managed Care

Survey Methodology:
This survey was conducted by Atomik Research. The sample of 1,003 adults (18 and older) in the United States was surveyed on December 17th,2019 . The margin of error is 3% and no additional weighting was done to the initial sample.

SOURCE Nurx

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.